Clostridium difficileinfection in cancer patients and hematopoietic stem cell transplant recipients
Authors:
- Teena ChopraTCTeena Chopra
- George J AlangadenGAGeorge J Alangaden
- Pranatharthi ChandrasekarPCPranatharthi Chandrasekar
- 1 October 2010
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Anti-infective Therapy
- Vol. 8 (10) , 1113-1119
Abstract
Clostridium difficile has become the most common bacterial cause of nosocomial diarrhea. High rates of C. difficile infection (CDI) coupled with increasing morbidity and mortality attributed to CDI have sparked a renewed interest in this disease. Emergence of hypervirulent strains, rising rates of severe and recurrent infection and associated infection control challenges, and diagnostic and therapeutic dilemmas are major issues in the non-oncology population. Scant data on CDI exist in the cancer/transplant population. The purpose of this article is to describe the epidemiology, pathogenesis and management of CDI in patients receiving cancer chemotherapeutic agents, and in hematopoietic stem cell transplant recipients.Keywords
This publication has 57 references indexed in Scilit:
- Clostridium difficile— More Difficult Than EverNew England Journal of Medicine, 2008
- Clostridium difficile-associated disease in human stem cell transplant recipients: coming epidemic or false alarm?Bone Marrow Transplantation, 2008
- The Challenges Posed by Reemerging Clostridium difficile InfectionClinical Infectious Diseases, 2007
- Clostridium difficile-Associated DiseaseDrugs, 2007
- Clostridium difficileInfection in Patients Discharged from US Short-stay Hospitals, 1996–20031Emerging Infectious Diseases, 2006
- An Epidemic, Toxin Gene–Variant Strain ofClostridium difficileNew England Journal of Medicine, 2005
- Antibiotic-Associated DiarrheaNew England Journal of Medicine, 2002
- Incidence and outcome of Clostridium difficile infection following autologous peripheral blood stem cell transplantationBone Marrow Transplantation, 1999
- Clostridium difficile ColitisNew England Journal of Medicine, 1994
- Antibiotic-Associated Pseudomembranous Colitis Due to Toxin-Producing ClostridiaNew England Journal of Medicine, 1978